A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults Journal Article


Authors: Perez-Andreu, V.; Roberts, K. G.; Xu, H.; Smith, C.; Zhang, H.; Yang, W.; Harvey, R. C.; Payne-Turner, D.; Devidas, M.; Cheng, I. M.; Carroll, W. L.; Heerema, N. A.; Carroll, A. J.; Raetz, E. A.; Gastier-Foster, J. M.; Marcucci, G.; Bloomfield, C. D.; Mrózek, K.; Kohlschmidt, J.; Stock, W.; Kornblau, S. M.; Konopleva, M.; Paietta, E.; Rowe, J. M.; Luger, S. M.; Tallman, M. S.; Dean, M.; Burchard, E. G.; Torgerson, D. G.; Yue, F.; Wang, Y.; Pui, C. H.; Jeha, S.; Relling, M. V.; Evans, W. E.; Gerhard, D. S.; Loh, M. L.; Willman, C. L.; Hunger, S. P.; Mullighan, C. G.; Yang, J. J.
Article Title: A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults
Abstract: Acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYA) is characterized by distinct presenting features and inferior prognosis compared with pediatric ALL. We performed a genome-wide association study (GWAS) to comprehensively identify inherited genetic variants associated with susceptibility to AYA ALL. In the discovery GWAS, we compared genotype frequency at 635 297 single nucleotide polymorphisms(SNPs) in 308AYAALL cases and 6,661 non-ALL controls by using a logistic regression model with genetic ancestry as a covariate. SNPs that reached P ≤ 5 × 10-8 in GWAS were tested in an independent cohort of 162 AYA ALL cases and 5,755 non-ALL controls. We identified a single genome-wide significant susceptibility locus in GATA3: rs3824662, odds ratio (OR), 1.77 (P = 2.8 × 10-10) and rs3781093, OR, 1.73 (P = 3.2 × 10-9). These findings were validated in the replication cohort. The risk allele at rs3824662 was most frequent in Philadelphia chromosome (Ph)-like ALL but also conferred susceptibility to non-Ph-like ALL in AYAs. In 1,827 non-selected ALL cases, the risk allele frequency at this SNP was positively correlated with age at diagnosis (P = 6.29 × 10-11). Our results from this first GWAS of AYA ALL susceptibility point to unique biology underlying leukemogenesis and potentially distinct disease etiology by age group.
Keywords: adolescent; adult; controlled study; young adult; unclassified drug; major clinical study; single nucleotide polymorphism; cancer risk; comparative study; cancer diagnosis; allele; transcription factor gata 3; gene expression; protein; genetic association; genetic variability; genotype; gene frequency; acute lymphoblastic leukemia; groups by age; risk assessment; genetic susceptibility; leukemogenesis; genetic risk; logistic regression analysis; philadelphia 1 chromosome; genetic identification; gene replication; adult disease; cancer prognosis; human; priority journal; article; adolescent disease; arid5b protein; ikaros transcription factor 1; pip4k2a protein
Journal Title: Blood
Volume: 125
Issue: 4
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2015-01-22
Start Page: 680
End Page: 686
Language: English
DOI: 10.1182/blood-2014-09-595744
PROVIDER: scopus
PMCID: PMC4304112
PUBMED: 25468567
DOI/URL:
Notes: Export Date: 2 March 2015 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman